✦ LIBER ✦

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

✍ Scribed by Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh Park, Se Hoon Park, Sun Young Kim, Ji Yeon Baek, Jee Hyun Kim, Keun-Wook Lee, Tae-You Kim, Tae Won Kim

Book ID: 118299125
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 260 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9853-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab Combined With Chemotherapy i

Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study

✍ Jaafar Bennouna; Christophe Borg; Jean-Pierre Delord; Faress Husseini; Véronique 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 312 KB

Prognostic Value of the Combination of C

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

✍ Sastre, Javier; Vidaurreta, Marta; Gómez, Auxiliadora; Rivera, Fernando; Massutí 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 686 KB

Phase Ib Study of Drozitumab Combined Wi

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

✍ Rocha Lima, Caio M.; Bayraktar, Soley; Flores, Aurea M.; MacIntyre, Jessica; Mon 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 223 KB

Phase II study of combined chemotherapy

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

A Phase 1B Study of Dulanermin in Combin

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

✍ Wainberg, Zev A.; Messersmith, Wells A.; Peddi, Parvin F.; Kapp, Amy V.; Ashkena 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 608 KB

6049 Phase II trial of combined chemothe

6049 Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer

✍ Hatanaka, K.; Komatsu, Y.; Yuki, S.; Nakamura, M.; Miyagishima, T.; Kudo, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB